Twinrix Paediatric

hepatitis A virus (inactivated);hepatitis B surface antigen · GlaxoSmithKline Biologicals S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Twinrix Paediatric, covering 2024-02-07 to 2026-08-03. Get the full timeline:

Most recent: EMA Authorised: Twinrix Paediatric (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.